CDH1 and neoplasm: p53 can affect cell motility through affecting the PI3-kinase/Rac1 pathway in the presence of mitogenic factors in both normal cells and tumor cells [41] and forms a complex with MDM2 and an invasion promotor named SLUG, an E-cadherin transcription inhibitor, leading to degradation of the complex [42].